FDA Should Allow Third-Party Electronic Storage Of Clinical Data – PhRMA
Executive Summary
FDA should permit electronic storage of clinical data by third parties, the Pharmaceutical Research & Manufacturers of America says in comments on the agency's 1Part 11 electronic records draft guidance
You may also be interested in...
Clinical Trials Computerized Systems Guidance Issued; GSK Sees Savings
GlaxoSmithKline expects significant savings through the elimination of data managers as the company moves to computerize its clinical trial data, the company said
Clinical Trials Computerized Systems Guidance Issued; GSK Sees Savings
GlaxoSmithKline expects significant savings through the elimination of data managers as the company moves to computerize its clinical trial data, the company said
FDA Guidance On Electronic Clinical Trial Data Slated For Late August
FDA plans to publish a draft guidance on the use of computerized systems in clinical trials by the end of August